Related Experiment Video
Updated: Feb 20, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Lipid accumulation product (LAP) index and its relation to anthropometric, metabolic and liver function factors in
Sanaz Bohlouli Sardroudi1, Sara Arefhosseini1, Mehrangiz Ebrahimi-Mameghani2
1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Objective:
This study aimed to assess the association between lipid accumulation product (LAP) index, a novel index combining waist circumference (WC) and triglyceride levels, and anthropometric indices, metabolic factors and hepatic function markers in obese subjects with non-alcoholic fatty liver disease (NAFLD).
Design:
Cross-sectional study.
Setting:
Specialised and subspecialised outpatient clinics of Tabriz University of Medical Sciences.
Participants:
Overall, 232 adult patients with obesity and ultrasound-proven NAFLD were included in the present study.
Outcome Measures:
Anthropometric measurements (body weight, height and waist and hip circumferences) were measured, and serum levels of glucose, lipid profile, ferritin and liver enzymes were assessed subsequent to an overnight fasting.
Results:
Mild and Moderate NAFLD were found in 43.5% and 48.2% of the participants, respectively. LAP index markedly increased with higher grades of steatosis, showing values of 63.72±22.26, 84.57±44.96 and 112.14±56.97 for healthy, grade I and grade II groups, respectively (p<0.001). There were significant differences in body weight (p=0.003), WC (p<0.001), fasting blood sugar (FBS) (p=0.004) and lipid profile (p<0.001) among LAP index quartiles. Moreover, the LAP index was positively correlated with body weight, liver function and, as expected, with lipid profile in all of the subjects with NAFLD. Sex differences showed an additional marked association of LAP with FBS (r=0.363 and p<0.001, respectively) and glycosylated haemoglobin (r=0.321 and p=0.002, respectively) in males and serum aspartate aminotransferase levels in females (r=0.223 and p=0.009, respectively).
Conclusions:
In conclusion, the LAP index was not only associated with anthropometric indices, metabolic parameters and hepatic function markers, but also increased in line with higher grades of liver steatosis in NAFLD.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity
Drug Dosing: Obese Patients
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

